ARCHIVES

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

This article is from The Cancer Letter archive.

Vol. 33 No. 13 | April 6, 2007

Download PDF Visit The Full Archive

Related Articles

NIH grant success rate drops to under 20 percent after 2011 budget cuts

May 13, 2011

In Brief: Gaus Heads AHCPR; Lineberger Names New Leadership In Oncology and Clinical Research

July 22, 1994

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

September 8, 1978

At AAAS Meeting, David Baltimore Comments on Bush Administration Science Policy.

March 3, 2006

Summit Tells Women To Get A Mammogram, Encourages Others, Too

September 29, 1989

HHS Orders Gallo Forum Canceled; Meeting May Be Held After OSI report final – Calabresi

July 3, 1992